Tactile Systems Technology's top three insider shareholders as of September 29, 2026 are Sheri Louise Dodd (Chief Executive Officer, 232.91K shares), Daniel L. Reuvers (President And Ceo, 146.44K shares), Elaine M. Birkemeyer (Chief Financial Officer, 130.19K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sheri Louise Dodd | Chief Executive Officer | 232,907 | 0 | 232,907 | 20.5% | 12 Aug, 2026 |
| 2 | Daniel L. Reuvers | President And Ceo | 146,442 | 0 | 146,442 | 12.9% | 13 Mar, 2025 |
| 3 | Elaine M. Birkemeyer | Chief Financial Officer | 130,188 | 0 | 130,188 | 11.4% | 13 May, 2026 |
| 4 | Kristie Burns | Sr. Vp Mktg Clinical Affairs | 82,581 | 0 | 82,581 | 7.3% | 26 Feb, 2026 |
| 5 | Kevin H Roche | Director | 66,228 | 0 | 66,228 | 5.8% | 05 Oct, 2021 |
| 6 | Raymond Huggenberger | Director | 62,841 | 0 | 62,841 | 5.5% | 08 May, 2026 |
| 7 | David Brent Shafer | Director | 55,343 | 0 | 55,343 | 4.9% | 08 May, 2026 |
| 8 | Valerie L. Asbury | Director | 55,343 | 0 | 55,343 | 4.9% | 08 May, 2026 |
| 9 | William W Burke | Director | 55,041 | 0 | 55,041 | 4.8% | 08 May, 2026 |
| 10 | Brent Moen | Chief Financial Officer | 48,760 | 0 | 48,760 | 4.3% | 03 Mar, 2023 |
| 11 | Carmen B Volkart | Director | 44,219 | 0 | 44,219 | 3.9% | 08 May, 2026 |
| 12 | Boyd Vindell Washington | Director | 41,768 | 0 | 41,768 | 3.7% | 08 May, 2026 |
| 13 | Sherri Lee Ferstler | Senior Vp, Sales | 38,764 | 0 | 38,764 | 3.4% | 14 Aug, 2024 |
| 14 | Eric Pauls | Senior Vp, Sales | 29,498 | 0 | 29,498 | 2.6% | 10 May, 2023 |
| 15 | Laura G. King | Director | 25,569 | 0 | 25,569 | 2.2% | 08 May, 2026 |
| 16 | Deepti Jain | Director | 15,448 | 0 | 15,448 | 1.4% | 11 May, 2022 |
| 17 | Andrea Pearson | Director | 7,373 | 0 | 7,373 | 0.6% | 08 May, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 10 Aug, 2026 | Sheri Louise Dodd | Chief Executive Officer | Disposed S | 10,978 | $29.44 | $323.24K | 232,907 | Direct |
| 11 May, 2026 | Elaine M. Birkemeyer | Chief Financial Officer | Disposed S | 4,631 | $24.49 | $113.40K | 130,188 | Direct |
| 06 May, 2026 | David Brent Shafer | Director | Acquired A | 6,521 | $0.00 | $0 | 55,343 | Direct |
| 06 May, 2026 | Boyd Vindell Washington | Director | Acquired A | 6,521 | $0.00 | $0 | 41,768 | Direct |
| 06 May, 2026 | Andrea Pearson | Director | Acquired A | 6,521 | $0.00 | $0 | 7,373 | Direct |
| 06 May, 2026 | William W Burke | Director | Acquired A | 6,521 | $0.00 | $0 | 55,041 | Direct |
| 06 May, 2026 | Carmen B Volkart | Director | Acquired A | 6,521 | $0.00 | $0 | 44,219 | Direct |
| 06 May, 2026 | Raymond Huggenberger | Director | Acquired A | 6,521 | $0.00 | $0 | 62,841 | Direct |
| 06 May, 2026 | Valerie L. Asbury | Director | Acquired A | 6,521 | $0.00 | $0 | 55,343 | Direct |
| 06 May, 2026 | Laura G. King | Director | Acquired A | 6,521 | $0.00 | $0 | 25,569 | Direct |
| 09 Mar, 2026 | Andrea Pearson | Director | Acquired A | 852 | $0.00 | $0 | 852 | Direct |
| 24 Feb, 2026 | Kristie Burns | Sr. Vp Mktg Clinical Affairs | Disposed S | 6,246 | $28.94 | $180.76K | 82,581 | Direct |
| 24 Feb, 2026 | Sheri Louise Dodd | Chief Executive Officer | Disposed S | 10,993 | $28.94 | $318.14K | 243,885 | Direct |
| 24 Feb, 2026 | Elaine M. Birkemeyer | Chief Financial Officer | Disposed S | 7,701 | $28.94 | $222.88K | 134,819 | Direct |
| 20 Feb, 2026 | Sheri Louise Dodd | Chief Executive Officer | Acquired A | 19,751 | $0.00 | $0 | 241,902 | Direct |
| 20 Feb, 2026 | Elaine M. Birkemeyer | Chief Financial Officer | Acquired A | 3,579 | $0.00 | $0 | 125,698 | Direct |
| 20 Feb, 2026 | Kristie Burns | Sr. Vp Mktg Clinical Affairs | Acquired A | 3,490 | $0.00 | $0 | 82,085 | Direct |
| 20 Feb, 2026 | Elaine M. Birkemeyer | Chief Financial Officer | Acquired A | 6,765 | $0.00 | $0 | 132,463 | Direct |
| 20 Feb, 2026 | Kristie Burns | Sr. Vp Mktg Clinical Affairs | Acquired A | 4,058 | $0.00 | $0 | 86,143 | Direct |
| 20 Feb, 2026 | Sheri Louise Dodd | Chief Executive Officer | Acquired A | 28,216 | $0.00 | $0 | 270,118 | Direct |